We have recently used the CRISPR/Cas9 technology to insert a FLAG-tag sequence at the 3’ end of the SSX2 gene in human SYO-1 cells (a well-established synovial sarcoma cell line) (Supplementary Figure S1A) (Patel et al., 2019). Here, SSX2 is linked to synovial sarcoma.